HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. typhi (NARST) era in South India.

Abstract
The epidemiology of typhoid fever in South Asia has changed. Multi-drug resistant (MDR) Salmonella typhi ( S. typhi) is now frequently resistant to nalidixic acid and thus labelled NARST. Treatment failure with the use of fluoroquinolones has been widely noted, forcing clinicians to adopt alternative treatment strategies. In this observational study, we looked at various treatment regimens and correlated clinical and microbiological outcomes. In 146 hospitalised adults, the median minimum inhibitory concentration (MIC) for ciprofloxacin was 0.38 µg/mL with a median fever clearance time (FCT) of eight days (range = 2-35 days). Of the regimens used, gatifloxacin and azithromycin had a shorter FCT of six days compared to ceftriaxone (ten days; P < 0.001). Though mortality and relapse in our cohort was low, NARST seemed to correlate with mortality ( P = 0.006). Gatifloxacin or azithromycin clearly emerge as the drugs of choice for treatment of typhoid in South India.
AuthorsRini Bandyopadhyay, Veeraghavan Balaji, Bijesh Yadav, Sudha Jasmine, Sowmya Sathyendra, Priscilla Rupali
JournalTropical doctor (Trop Doct) Vol. 48 Issue 3 Pg. 182-188 (Jul 2018) ISSN: 1758-1133 [Electronic] England
PMID29495943 (Publication Type: Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Fluoroquinolones
  • Nalidixic Acid
  • Ciprofloxacin
  • Azithromycin
  • Gatifloxacin
Topics
  • Adult
  • Anti-Bacterial Agents (therapeutic use)
  • Anti-Infective Agents (therapeutic use)
  • Azithromycin (therapeutic use)
  • Ciprofloxacin (therapeutic use)
  • Cohort Studies
  • Drug Resistance, Multiple, Bacterial
  • Female
  • Fluoroquinolones (therapeutic use)
  • Gatifloxacin
  • Hospitalization
  • Humans
  • India (epidemiology)
  • Male
  • Microbial Sensitivity Tests
  • Nalidixic Acid (therapeutic use)
  • Recurrence
  • Salmonella typhi (drug effects)
  • Treatment Outcome
  • Typhoid Fever (drug therapy, epidemiology, microbiology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: